UROPLASTY INC-NEW
UPI
UPI was delisted on the 31st of March, 2015.
31 hedge funds and large institutions have $29.7M invested in UROPLASTY INC-NEW in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 7 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less capital invested
Capital invested by funds: $32.2M → $29.7M (-$2.56M)
16% less funds holding
Funds holding: 37 → 31 (-6)
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $50K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Amici Capital
New York
|
+$457K |
| 2 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
+$125K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$115K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$94.1K |
| 5 |
PA
Perceptive Advisors
New York
|
+$75.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sophrosyne Capital
New York
|
-$463K |
| 2 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
-$327K |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$209K |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$175K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$121K |
UPI Hedge Fund Activity: Q3 2014 in Review
31 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in UROPLASTY INC-NEW (UPI) for Q3 2014, worth a combined $29.7M — down 7.9% from $32.2M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of UPI and 1 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 11 added.
The largest buyer was Amici Capital, adding an estimated $457K. The largest seller was Sophrosyne Capital, exiting entirely with an estimated $463K sold.
- 31 institutional investors held UROPLASTY INC-NEW (UPI) as of Q3 2014, down from 37 in Q2 2014.
- Funds reported $29.7M of UROPLASTY INC-NEW stock for Q3 2014, down 7.9% quarter-over-quarter.
- 1 fund opened new UROPLASTY INC-NEW positions in Q3 2014 and 7 closed out, a net change of -6 holders.
- The largest UROPLASTY INC-NEW buyer in Q3 2014 was Amici Capital, an estimated $457K added.
- The largest UROPLASTY INC-NEW seller in Q3 2014 was Sophrosyne Capital, an estimated $463K sold.
Based on aggregated 13F filings for Q3 2014.